FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Central Admixture Pharmacy Services oxyTOCIN 15 units added to 0 Recall

oxyTOCIN 15 units added to 0

Central Admixture Pharmacy Services, Inc. · Allentown, PA

Risk level
Class II
Reported by FDA
May 31, 2023
Recall ID
D-0708-2023
Check your lot numberHow we source this data

Summary

Central Admixture Pharmacy Services recalled oxyTOCIN 15 units added to 0 starting Apr 28, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0708-2023 on May 31, 2023. Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Product description

oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6042-1.

Lot numbers, UPCs & expiration codes

Lot # 37-883926, Exp 05/02/2023; 37-886032, Exp 05/10/2023; 37-887681, Exp 05/17/2023; 37-888317, Exp 05/21/2023; 37-890906, Exp 05/30/2023; 37-892146, Exp 06/05/2023; 37-892507, Exp 06/06/2023; 37-894483, Exp 06/13/2023; 37-896595, Exp 06/21/2023; 37-898568, Exp 06/29/2023

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0708-2023
Classification
Class II
Status
Terminated
Recall initiated
Apr 28, 2023
FDA report date
May 31, 2023
Quantity
3865 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Central Admixture Pharmacy Services, Inc.

Original FDA data

Every field from FDA enforcement report D-0708-2023, exactly as published.

Show all FDA fields
City
Allentown
State
PA
Status
Terminated
Country
United States
Event ID
92253
Address
6580 Snowdrift Rd Ste 100
Code information
Lot # 37-883926, Exp 05/02/2023; 37-886032, Exp 05/10/2023; 37-887681, Exp 05/17/2023; 37-888317, Exp 05/21/2023; 37-890906, Exp 05/30/2023; 37-892146, Exp 06/05/2023; 37-892507, Exp 06/06/2023; 37-894483, Exp 06/13/2023; 37-896595, Exp 06/21/2023; 37-898568, Exp 06/29/2023
Postal code
18106-9331
Report date
May 31, 2023
Product type
Drugs
Recall number
D-0708-2023
Classification
Class II
Recalling firm
Central Admixture Pharmacy Services, Inc.
Product quantity
3865 bags
Termination date
Jun 22, 2025
Reason for recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Voluntary / mandated
Voluntary: Firm initiated
Product description
oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6042-1.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Apr 28, 2023
Initial firm notification
E-Mail
Center classification date
May 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0708-2023, published May 31, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls